No black box warning on record for Midodrine Hydrochloride

As of the latest FDA labeling reviewed, Midodrine Hydrochloride (MIDODRINE HYDROCHLORIDE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Midodrine Hydrochloride medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS Supine Hypertension: The most potentially serious adverse reaction associated with midodrine therapy is marked elevation of supine arterial blood pressure (supine hypertension). Systolic pressure of about 200 mmHg were seen overall in about 13.4% of patients given 10 mg of midodrine . Systolic elevations of this degree were most likely to be observed in patients with relatively elevated p

No black box warning on record for Midodrine Hydrochloride

Other warnings & precautions

WARNINGS Supine Hypertension: The most potentially serious adverse reaction associated with midodrine therapy is marked elevation of supine arterial blood pressure (supine hypertension). Systolic pressure of about 200 mmHg were seen overall in about 13.4% of patients given 10 mg of midodrine . Systolic elevations of this degree were most likely to be observed in patients with relatively elevated p

Midodrine Hydrochloride Black Box Warning

No black box warning on record for Midodrine Hydrochloride

Other warnings & precautions

Midodrine Hydrochloride Black Box Warning

No black box warning on record for Midodrine Hydrochloride

Other warnings & precautions